» Articles » PMID: 35428234

Is Repeat Fine Needle Aspiration Required in Thyroid Nodules with Initial Benign Cytology? Results from a Large Irish Series

Abstract

Methods: We retrospectively examined 658 nodules in 653 (429 female) patients between January 2013 to December 2017. All FNA biopsies (FNABs) were performed under ultrasound (US) guidance by a radiologist with expertise in thyroid pathology. Nodules were cytologically classified according to the UK Royal College of Pathologists guidelines. Decisions about further management were made at a regular thyroid multidisciplinary meeting. Follow up of the Thy 2 nodules was determined based on clinical and radiological criteria.

Results: The mean age (± SD) was 53.2 (14.6) years. Five hundred out of 658 (76.0%) nodules were classified as Thy 2 (benign) after the first FNAB. Of these thyroid nodules initially classified as benign, 208 (41.6%) underwent repeat FNAB and 9 (1.8%) were surgically removed without repeat FNAB. The remainder were followed up clinically and/or radiologically. Seven (1.4%) of nodules initially classified as Thy 2 were later shown to be or to harbor malignancy after a follow-up of 74.5 (± 19.7) months. Papillary thyroid microcarcinomas were found co-incidentally in two thyroid glands of benign nodules, giving a true prevalence of 5/500 (1.0%).

Conclusions: With a well targeted FNAB, the false negative rate of an initial benign thyroid FNA is very low thus routine second FNAB is not required in patients with a thyroid nodule initially deemed benign. Multidisciplinary input is imperative in informing decision making.

Citing Articles

Value of repeated US-guided fine-needle aspiration (US-FNAB) in the follow-up of benign thyroid nodules: a real-life study based on the MoCyThy (Modena's Cytology of the Thyroid) DATABASE with a revision of the literature.

De Vincentis S, Brigante G, Ansaloni A, Madeo B, Zirilli L, Diazzi C Endocrine. 2023; 84(1):193-202.

PMID: 38123877 DOI: 10.1007/s12020-023-03641-y.

References
1.
Alexander E, Hurwitz S, Heering J, Benson C, Frates M, Doubilet P . Natural history of benign solid and cystic thyroid nodules. Ann Intern Med. 2003; 138(4):315-8. DOI: 10.7326/0003-4819-138-4-200302180-00010. View

2.
Medici M, Liu X, Kwong N, Angell T, Marqusee E, Kim M . Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort study. BMC Med. 2016; 14:11. PMC: 4730757. DOI: 10.1186/s12916-016-0554-1. View

3.
Haugen B . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?. Cancer. 2016; 123(3):372-381. DOI: 10.1002/cncr.30360. View

4.
Ardito G, Revelli L, Giustozzi E, Salvatori M, Fadda G, Ardito F . Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy. Clin Nucl Med. 2012; 38(1):25-8. DOI: 10.1097/RLU.0b013e318279bc65. View

5.
Cesur M, Corapcioglu D, Bulut S, Gursoy A, Yilmaz A, Erdogan N . Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules. Thyroid. 2006; 16(6):555-61. DOI: 10.1089/thy.2006.16.555. View